blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1833494

EP1833494 - REGENERATION OF PANCREATIC ISLETS BY AMNIOTIC FLUID STEM CELL THERAPY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.03.2017
Database last updated on 14.09.2024
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): IS		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
Wake Forest University Health Sciences
One Technology Place
200 East First Street
Suite 101
Winston-Salem
North Carolina 27101 / US
[2016/20]
Former [2007/38]For all designated states
Wake Forest University Health Sciences
One Technology Place, 200 East First Street, Suite 101 Winston-Salem
North Carolina 27101 / US
Inventor(s)01 / ATALA, Anthony
2661 Reynolds Drive
Winston-Salem, North Carolina 27157 / US
02 / MILANESI, Anna
1430 North Harper Avenue 306
West Hollywood, CA 90046 / US
03 / SOKER, Shay
9 Roundtree Court
Greensboro, North Carolina 27410 / US
 [2007/49]
Former [2007/38]01 / ATALA, Anthony
2661 Reynolds Drive
Winston-Salem, North Carolina 27157 / US
02 / MILANESI, Anna
370-s Glendare Court
Winston-Salem, North Carolina 27104 / US
03 / SOKER, Shay
9 Roundtree Court
Greensboro, North Carolina 27410 / US
Representative(s)Chapman, Paul Gilmour, et al
Marks & Clerk LLP
Atholl Exchange
6 Canning Street
Edinburgh EH3 8EG / GB
[2013/42]
Former [2008/33]Chapman, Paul Gilmour, et al
Marks & Clerk 19 Royal Exchange Square Glasgow
G1 3AE / GB
Former [2007/38]Chapman, Paul Gilmour, et al
Marks & Clerk 19 Royal Exchange Square
GB-Glasgow G1 3AE / GB
Application number, filing date06717519.006.01.2006
[2007/38]
WO2006US00334
Priority number, dateUS20050642381P07.01.2005         Original published format: US 642381 P
[2007/38]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006074308
Date:13.07.2006
Language:EN
[2006/28]
Type: A2 Application without search report 
No.:EP1833494
Date:19.09.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 13.07.2006 takes the place of the publication of the European patent application.
[2007/38]
Type: B1 Patent specification 
No.:EP1833494
Date:18.05.2016
Language:EN
[2016/20]
Search report(s)International search report - published on:US09.04.2009
(Supplementary) European search report - dispatched on:EP19.04.2010
ClassificationIPC:A01N63/00, A01N65/00, A61K35/50, A61P5/48
[2010/18]
CPC:
A61K35/39 (EP,US); A61K35/50 (EP,US); A61K38/1709 (EP,US);
A61K9/0019 (EP,US); A61P3/10 (EP); A61P5/48 (EP);
C12N5/0605 (EP,US); C12N5/0607 (EP,US); C12N5/0676 (EP,US);
A61K35/12 (EP,US); A61K38/00 (US); C12N2501/60 (EP,US);
C12N2506/02 (EP,US); C12N2506/03 (EP,US); C12N2510/00 (EP,US) (-)
Former IPC [2009/23]A01N63/00, A01N65/00
Former IPC [2007/38]A61K35/14
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/20]
Former [2007/38]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:WIEDERHERSTELLUNG DER LANGERHANSSCHEN ZELLEN DURCH FRUCHTWASSERSTAMMZELLENTHERAPIE[2007/38]
English:REGENERATION OF PANCREATIC ISLETS BY AMNIOTIC FLUID STEM CELL THERAPY[2007/38]
French:REGENERATION DES ILOTS PANCREATIQUES PAR TRAITEMENT DES CELLULES SOUCHES DU LIQUIDE AMNIOTIQUE[2007/38]
Entry into regional phase06.07.2007National basic fee paid 
06.07.2007Search fee paid 
06.07.2007Designation fee(s) paid 
06.07.2007Examination fee paid 
Examination procedure06.07.2007Examination requested  [2007/38]
25.08.2010Despatch of a communication from the examining division (Time limit: M06)
04.03.2011Reply to a communication from the examining division
12.07.2013Despatch of a communication from the examining division (Time limit: M06)
17.01.2014Reply to a communication from the examining division
19.05.2014Despatch of a communication from the examining division (Time limit: M04)
18.09.2014Reply to a communication from the examining division
21.08.2015Despatch of a communication from the examining division (Time limit: M02)
22.08.2015Reply to a communication from the examining division
01.10.2015Communication of intention to grant the patent
11.02.2016Fee for grant paid
11.02.2016Receipt of the translation of the claim(s)
01.04.2016Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
01.04.2016Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.08.2010
Opposition(s)21.02.2017No opposition filed within time limit [2017/17]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
01.04.2016Request for further processing filed
01.04.2016Full payment received (date of receipt of payment)
Request granted
15.04.2016Decision despatched
Fees paidRenewal fee
06.07.2007Renewal fee patent year 03
30.01.2009Renewal fee patent year 04
25.01.2010Renewal fee patent year 05
25.01.2011Renewal fee patent year 06
25.01.2012Renewal fee patent year 07
25.01.2013Renewal fee patent year 08
27.01.2014Renewal fee patent year 09
27.01.2015Renewal fee patent year 10
27.01.2016Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.01.2006
AT18.05.2016
BE18.05.2016
BG18.05.2016
CY18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
ES18.05.2016
FI18.05.2016
IT18.05.2016
LT18.05.2016
LV18.05.2016
MC18.05.2016
NL18.05.2016
PL18.05.2016
RO18.05.2016
SE18.05.2016
SI18.05.2016
SK18.05.2016
TR18.05.2016
GR19.08.2016
IS18.09.2016
PT19.09.2016
IE06.01.2017
LU06.01.2017
CH31.01.2017
LI31.01.2017
[2020/33]
Former [2020/15]HU06.01.2006
AT18.05.2016
BE18.05.2016
BG18.05.2016
CY18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
ES18.05.2016
FI18.05.2016
IT18.05.2016
LT18.05.2016
LV18.05.2016
MC18.05.2016
NL18.05.2016
PL18.05.2016
RO18.05.2016
SE18.05.2016
SI18.05.2016
SK18.05.2016
TR18.05.2016
GR19.08.2016
PT19.09.2016
IE06.01.2017
LU06.01.2017
CH31.01.2017
LI31.01.2017
Former [2019/46]HU06.01.2006
AT18.05.2016
BE18.05.2016
BG18.05.2016
CY18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
ES18.05.2016
FI18.05.2016
IT18.05.2016
LT18.05.2016
LV18.05.2016
MC18.05.2016
NL18.05.2016
PL18.05.2016
RO18.05.2016
SE18.05.2016
SI18.05.2016
SK18.05.2016
GR19.08.2016
PT19.09.2016
IE06.01.2017
LU06.01.2017
CH31.01.2017
LI31.01.2017
Former [2019/39]HU06.01.2006
AT18.05.2016
BE18.05.2016
BG18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
ES18.05.2016
FI18.05.2016
IT18.05.2016
LT18.05.2016
LV18.05.2016
MC18.05.2016
NL18.05.2016
PL18.05.2016
RO18.05.2016
SE18.05.2016
SI18.05.2016
SK18.05.2016
GR19.08.2016
PT19.09.2016
IE06.01.2017
LU06.01.2017
CH31.01.2017
LI31.01.2017
Former [2019/31]HU06.01.2006
AT18.05.2016
BE18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
ES18.05.2016
FI18.05.2016
IT18.05.2016
LT18.05.2016
LV18.05.2016
MC18.05.2016
NL18.05.2016
PL18.05.2016
RO18.05.2016
SE18.05.2016
SI18.05.2016
SK18.05.2016
GR19.08.2016
PT19.09.2016
IE06.01.2017
LU06.01.2017
CH31.01.2017
LI31.01.2017
Former [2018/13]AT18.05.2016
BE18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
ES18.05.2016
FI18.05.2016
IT18.05.2016
LT18.05.2016
LV18.05.2016
MC18.05.2016
NL18.05.2016
PL18.05.2016
RO18.05.2016
SE18.05.2016
SI18.05.2016
SK18.05.2016
GR19.08.2016
PT19.09.2016
IE06.01.2017
LU06.01.2017
CH31.01.2017
LI31.01.2017
Former [2017/51]AT18.05.2016
BE18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
ES18.05.2016
FI18.05.2016
IT18.05.2016
LT18.05.2016
LV18.05.2016
MC18.05.2016
NL18.05.2016
PL18.05.2016
RO18.05.2016
SE18.05.2016
SI18.05.2016
SK18.05.2016
GR19.08.2016
PT19.09.2016
LU06.01.2017
CH31.01.2017
LI31.01.2017
Former [2017/47]AT18.05.2016
BE18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
ES18.05.2016
FI18.05.2016
IT18.05.2016
LT18.05.2016
LV18.05.2016
MC18.05.2016
NL18.05.2016
PL18.05.2016
RO18.05.2016
SE18.05.2016
SI18.05.2016
SK18.05.2016
GR19.08.2016
PT19.09.2016
Former [2017/37]AT18.05.2016
BE18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
ES18.05.2016
FI18.05.2016
IT18.05.2016
LT18.05.2016
LV18.05.2016
NL18.05.2016
PL18.05.2016
RO18.05.2016
SE18.05.2016
SI18.05.2016
SK18.05.2016
GR19.08.2016
PT19.09.2016
Former [2017/11]AT18.05.2016
BE18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
ES18.05.2016
FI18.05.2016
IT18.05.2016
LT18.05.2016
LV18.05.2016
NL18.05.2016
PL18.05.2016
RO18.05.2016
SE18.05.2016
SK18.05.2016
GR19.08.2016
PT19.09.2016
Former [2017/10]BE18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
ES18.05.2016
FI18.05.2016
IT18.05.2016
LT18.05.2016
LV18.05.2016
NL18.05.2016
PL18.05.2016
RO18.05.2016
SE18.05.2016
SK18.05.2016
GR19.08.2016
PT19.09.2016
Former [2017/09]CZ18.05.2016
DK18.05.2016
EE18.05.2016
ES18.05.2016
FI18.05.2016
IT18.05.2016
LT18.05.2016
LV18.05.2016
NL18.05.2016
RO18.05.2016
SE18.05.2016
GR19.08.2016
PT19.09.2016
Former [2017/07]DK18.05.2016
ES18.05.2016
FI18.05.2016
IT18.05.2016
LT18.05.2016
LV18.05.2016
NL18.05.2016
SE18.05.2016
GR19.08.2016
PT19.09.2016
Former [2017/04]ES18.05.2016
FI18.05.2016
IT18.05.2016
LT18.05.2016
LV18.05.2016
NL18.05.2016
SE18.05.2016
GR19.08.2016
PT19.09.2016
Former [2016/52]ES18.05.2016
FI18.05.2016
LT18.05.2016
LV18.05.2016
NL18.05.2016
SE18.05.2016
GR19.08.2016
PT19.09.2016
Former [2016/51]ES18.05.2016
FI18.05.2016
LT18.05.2016
LV18.05.2016
NL18.05.2016
GR19.08.2016
PT19.09.2016
Former [2016/50]ES18.05.2016
FI18.05.2016
LT18.05.2016
LV18.05.2016
NL18.05.2016
Former [2016/49]FI18.05.2016
LT18.05.2016
NL18.05.2016
Former [2016/46]LT18.05.2016
Documents cited:Search[XI]WO03047607  ;
 [Y]WO0236751  (KOURION THERAPEUTICS GMBH [DE]) [Y] 1-35 * the whole document * * see esp. p. 7, end pf 3rd paragraph. *;
 [Y]US2002164307  (HABENER JOEL F [US], et al) [Y] 1-35 * paragraph [0121] - paragraph [0126] * * paragraphs [0205] , [0000] , [0208] *;
 [Y]WO03026584  (GEN HOSPITAL CORP [US], et al) [Y] 1-35 * page 3, paragraph 5 - page 6, paragraph 3; claims 1,3,11,13 *;
 [YP]US2005118712  (TSAI MING-SONG [TW], et al) [YP] 1-35 * paragraphs [0010] , [0016] , [0018] - [0020] - [0060] , [0087] *;
 [Y]  - TAMAGAWA T ET AL, "ESTABLISHMENT AND CHARACTERIZATION OF A PLURIPOTENT STEM CELL LINE DERIVED FROM HUMAN AMNIOTIC MEMBRANES AND INITIATION OF GERM LAYERS IN VITRO", HUMAN CELL, WILEY-BLACKWELL PUBLISHING LTD, UK; JP, (20040101), vol. y, no. 3, ISSN 0914-7470, pages 125 - 130, XP009075883 [Y] 1-35 * the whole document *
 [XI]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2003, no. 46, Database accession no. 2003-493589, XP002574798 & WO03047607 A1 20030612 (NIKAIDO T) [X] 1,4-9,17,20-27,29,32 * abstract * * the whole document * [I] 2,3,10-16,18,19,28,30,31,33-35
 [T]  - DE COPPI PAOLO ET AL, "Isolation of amniotic stem cell lines with potential for therapy.", NATURE BIOTECHNOLOGY JAN 2007, (200701), vol. 25, no. 1, ISSN 1087-0156, pages 100 - 106, XP002574799 [T] * page 100, column l, paragraph 1 * * abstract * * page 100, column r, paragraph 2 * * page 101, column l, paragraph 3 - column r, paragraph 2 * * page 103, column r, paragraphs 2,5 *

DOI:   http://dx.doi.org/10.1038/nbt1274
 [Y]  - RAMIYA VIJAYAKUMAR K ET AL, "Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, (20000301), vol. 6, no. 3, ISSN 1078-8956, pages 278 - 282, XP000864764 [Y] 1-35 * the whole document *

DOI:   http://dx.doi.org/10.1038/73128
International search[X]WO03042405  (CHILDRENS MEDICAL CENTER [US], et al);
 [Y]US2006216277  (EFRAT SHIMON [IL])
ExaminationWO03042405
    - MCKINNON C M ET AL, "PANCREATIC DUODENAL HOMEOBOX-1, PDX-1, A MAJOR REGULATOR OF BETA CELL IDENTITY AND FUNCTION", DIABETOLOGIA, SPRINGER, BERLIN, DE, (20011001), vol. 44, no. 10, doi:10.1007/S001250100628, ISSN 0012-186X, pages 1203 - 1214, XP001176889

DOI:   http://dx.doi.org/10.1007/s001250100628
    - TANG D-Q ET AL, "In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow", DIABETES, AMERICAN DIABETES ASSOCIATION, US, (20040701), vol. 53, doi:10.2337/DIABETES.53.7.1721, ISSN 0012-1797, pages 1721 - 1732, XP003004042

DOI:   http://dx.doi.org/10.2337/diabetes.53.7.1721
    - VALERIE A MCLIN ET AL, "Organogenesis: Making Pancreas from Liver", CURRENT BIOLOGY, (20030201), vol. 13, no. 3, doi:10.1016/S0960-9822(03)00036-8, ISSN 0960-9822, pages R96 - R98, XP055070086

DOI:   http://dx.doi.org/10.1016/S0960-9822(03)00036-8
by applicantWO03042405
 US5702444
    - RITZ, E.; SCHOMIG M., "The diabetic patient with renal failure", NEFROLOGIA, (2000), vol. 20, pages 16 - 24
    - BROWNLEE M., "Biochemistry and molecular cell biology of diabetic complications", NATURE, (2001), vol. 414, pages 813 - 820
    - RAJAGOPAL, J. ET AL., "Insulin staining of ES cell progeny from insulin uptake", SCIENCE, (2003), vol. 299, page 363
    - SORIA, B. ET AL., "Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice", DIABETES, (2000), vol. 49, no. 2, doi:doi:10.2337/diabetes.49.2.157, pages 157 - 62, XP002183378

DOI:   http://dx.doi.org/10.2337/diabetes.49.2.157
    - DECOPPI PAOLO ET AL., NATURE BIOTECH., (2007), vol. 25, pages LOO - 106
    - T ANKER, P.S. ET AL., "Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation", BLOOD, (2003), vol. 102, no. 4, doi:doi:10.1182/blood-2003-04-1291, pages 1548 - 9, XP009085337

DOI:   http://dx.doi.org/10.1182/blood-2003-04-1291
    - PRUSA, A.R. ET AL., "Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?", HUM REPROD, (2003), vol. 18, no. 7, doi:doi:10.1093/humrep/deg279, pages 1489 - 93, XP002277347

DOI:   http://dx.doi.org/10.1093/humrep/deg279
    - KAVIANI, A. ET AL., "The amniotic fluid as a source of cells for fetal tissue engineering", J PEDIATR SURG, (2001), vol. 36, no. 11, pages 1662 - 5
    - PRUSA, A.R.; M. HENGSTSCHLAGER, "Amniotic fluid cells and human stem cell research: a new connection", MED SCI MONIT, (2002), vol. 8, no. 11, pages RA253 - 7, XP002419092
    - LAB INV, (2004), vol. 84, pages 607 - 617
    - OTONKOSKI, T. ET AL., "Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells", J CLIN INVEST, (1993), vol. 92, no. 3, doi:doi:10.1172/JCI116723, pages 1459 - 1466, XP009008891

DOI:   http://dx.doi.org/10.1172/JCI116723
    - HORI, Y. ET AL., "Growth inhibitor promote differentiation of insulin-producing tissue from embryonic stem cells", PNAS, (2002), vol. 99, doi:doi:10.1073/pnas.252618999, pages 16105 - 16110, XP002392968

DOI:   http://dx.doi.org/10.1073/pnas.252618999
    - NIELSEN, LL. ET AL., "Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes", REGUL PEPT., (20040215), vol. 117, no. 2, pages 77 - 88
    - LEON-QUINTO, T. ET AL., "In vitro direct differentiation of mouse embryonic stem cells into insulin-producing cells", DIABETOLOGIA, (2004), vol. 47, doi:doi:10.1007/s00125-004-1458-8, pages 1442 - 1451, XP002699175

DOI:   http://dx.doi.org/10.1007/s00125-004-1458-8
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.